During the past decade, Utrecht Institute for Pharmaceutical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Utrecht Institute for Pharmaceutical Sciences" #1 collaborator was "Takeda" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Utrecht Institute for Pharmaceutical Sciences" are "ADHD" (1 trials), "Alcoholism" (1 trials), "Insomnia" (1 trials) and "Seasonal Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Utrecht Institute for Pharmaceutical Sciences" in a lesser frequency.

Most popular intervention types in "Utrecht Institute for Pharmaceutical Sciences" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "1 week of treatment discontinuation" (1 trials), "Ramelteon 8 mg" (1 trials), "Zopiclone 7.5 mg" (1 trials), "alcohol" (1 trials) and "methylphenidate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Utrecht Institute for Pharmaceutical Sciences" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Utrecht Institute for Pharmaceutical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Utrecht Institute for Pharmaceutical Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Utrecht Institute for Pharmaceutical Sciences, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".